You are reading the October 2026 edition. Get the current edition for this market — $99/year →

Labor Market Pulse

Longview, TX Metro Edition

Focus: LIFE SCI

Longview unemployment rises, but scientific talent scarcity doesn't follow.

5.3%

Longview MSA unemployment rate

Up from 4.3% in March 2026

21.6%

Texas life sciences employer growth

Since 2019, outpacing talent pipeline growth

123,900

Longview nonfarm payrolls

Aug 2026, +300 monthly, +0.6% annual

$123,068

Texas pharma subsector wage avg

56.2% employer growth since 2019

This Month's Takeaways

01

Metro unemployment up, specialist scarcity unchanged.

Longview's unemployment rate rose from 4.3% to 5.3% between March and June 2026, but this slack concentrates in lower-skill occupations, not the credentialed scientific and regulatory roles life sciences employers compete for statewide.

02

Research Scientist pay climbs locally but still trails national rate.

Metro median advertised pay for Research Scientist reached $125,310, up significantly year-over-year but still $6,000 below the national median of $131,354 — a gap that may widen further if Houston's biomanufacturing buildout pulls senior scientific talent out of smaller Texas metros.

03

Clinical Research Associate pay signals a tightening pipeline.

Advertised CRA pay rose significantly both locally ($81,374) and nationally ($90,956), consistent with sustained clinical trial activity competing for a limited credentialed pool — a trend that should inform whether CRO partnerships or in-house clinical ops hiring better absorbs near-term cost increases.

04

Houston's manufacturing surge is a regional talent magnet, not just a Houston story.

Eli Lilly's $6.5B and Bristol Myers' $2.3B Generation Park facilities create over 600 new jobs each, raising the realistic recruiting radius for quality and manufacturing specialists that Longview-based employers may have assumed were locally available.

Longview MSA unemployment climbed to 5.3% in June 2026 from 4.3% in March, even as nonfarm payrolls edged up to 123,900 by August, pointing to a labor market adding jobs slowly while labor supply loosens. Manufacturing and healthcare remain the metro's largest employment bases, but neither shows the acceleration seen in Houston's biomanufacturing corridor or statewide construction and professional services growth, leaving Longview-based life sciences employers reliant on a shallow local specialist pool.

Rising metro unemployment alongside flat-to-soft payroll growth suggests Longview life sciences employers face less wage pressure on general lab and support roles than peer Texas metros, but credentialed scientific, quality, and regulatory talent remains scarce regardless of local slack — these roles draw from a statewide or national pool, not the Gregg County labor force. Build-vs-outsource calculus should account for the fact that Houston's Lilly and Bristol Myers manufacturing expansions are pulling experienced operators and quality specialists toward Generation Park, potentially widening the recruiting radius and cost needed to retain comparable talent in Longview. Consider reviewing whether current compensation for regulatory and senior research roles reflects statewide competition rather than local market softness.

Advertised Pay Indicators

Role P25 Median P75 Local Trend National Nat. Trend
Research Scientist $84,986 $125,310 $136,499 ↑ Significant increase $131,354 ↑ Significant increase
Clinical Research Associate $58,220 $81,374 $98,325 ↑ Significant increase $90,956 ↑ Significant increase
Lab Technician $37,740 $45,314 $49,226 → Stable $47,402 ↓ Moderate decline
Regulatory Affairs Specialist — — — — No data $104,000 → Stable
Clinical Data Manager — — — — No data $123,031 ↓ Moderate decline
Biostatistician — — — — No data $133,322 ↑ Moderate increase
Validation Engineer — — — — No data $108,377 ↑ Moderate increase

Some roles reflect state-level data where local metro sample size was insufficient.

Looking Ahead · Next 30–60 Days

Expected

BLS will release September 2026 Longview MSA unemployment and payroll data in mid-to-late October — watch whether the June-to-August softening trend continues, which would support more aggressive local hiring for non-credentialed roles.

Emerging pressure point

Houston's biomanufacturing expansion (Lilly, Bristol Myers at Generation Park) is scaling through 2026-2027; track whether Longview-based quality and manufacturing specialists are recruited away, which would tighten an already thin regional bench.

Worth watching

National biopharma layoffs (BioMarin, Bristol Myers Squibb) are concentrated in consolidation functions, not execution roles — monitor whether any displaced regulatory or CMC talent enters the Texas candidate pool via relocation.

Early indicator

San Jacinto College's NIBRT-licensed biotech training center, now a year into operation, may begin producing technician-level graduates — watch whether this eases Lab Technician hiring pressure in East Texas before it affects higher-credential roles.

WageScape Member Benefit

Monitor more markets, industries, and job families.

Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.

Pulse Plus

3 metro reports

$149/year

Pulse Pro

10 metro reports

$349/year

Enterprise

10+ markets

Contact us

WageTrak · 15% Member Discount

On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.

Forwarded This Briefing?

Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.